Author Archive | StuChapman

Role of Sorafenib in the Current Treatment Landscape for Previously Treated Advanced Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis of Efficacy and Safety

                  From left, top to bottom: Nicholas Vogelzang, MD, FASCO, FACP1; Thomas Hutson, DO, PharmD, FACP3; Marissa Blieden, MS: Corresponding Author4; Kyle Fahrbach, PhD5; Rachel Huelin, BA6; Adriana Valderrama, PhD, MBA7; Lonnie Wen, RPh, PhD8; Svetlana Babajanyan, MS, MD9  Not pictured: Thomas Powles, MBBS, MRCP, MD2 Affiliations are […]

Continue Reading 0

A Recap of Key Findings Offers
‘Reality Check’ on Essential Data, Trends

Jose A. Karam, MD Associate Professor, Department of Urology, Division of Surgery The University of Texas MD Anderson Cancer Center Houston, Texas If clinicians were looking for a signal to identify future directions and potential destinations in kidney cancer care and research, they might orient themselves with highlights from this year’s ASCO GU meeting. There […]

Continue Reading 0